214 results on '"Murray, James L."'
Search Results
2. Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence
3. Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence – Implications for vaccine trial design
4. A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-β
5. A phase II study of tipifarnib and gemcitabine in metastatic breast cancer
6. Drug Repurposing: New Treatments for Zika Virus Infection?
7. Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer
8. Seven Novel Probe Systems for Real-Time PCR Provide Absolute Single-Base Discrimination, Higher Signaling, and Generic Components
9. Nuclear trafficking of the HIV-1 pre-integration complex depends on the ADAM10 intracellular domain
10. Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer
11. Understanding Clinician EHR Data Quality for Reuse in Predictive Modelling.
12. A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer
13. Host factors mediating HIV-1 replication
14. A post-entry role for CD63 in early HIV-1 replication
15. A Role for H/ACA and C/D Small Nucleolar RNAs in Viral Replication
16. Staff Attitudes towards the Sexuality of Persons with Intellectual Disability.
17. Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial
18. Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancer
19. Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor–positive metastatic breast cancer
20. Expression and Relevance of TRPS-1: A New GATA Transcription Factor in Breast Cancer
21. A critical role for CD63 in HIV replication and infection of macrophages and cell lines
22. Quantitative Immunohistochemical Analysis and Prognostic Significance of TRPS-1, a New GATA Transcription Factor Family Member, in Breast Cancer
23. Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancer
24. Therapeutic Breast Cancer Vaccines: A New Strategy for Early-Stage Disease
25. Ii-Key/HER-2/neu MHC class-II antigenic epitope vaccine peptide for breast cancer
26. Accelerated HER-2 degradation enhanced ovarian tumor recognition by CTL. Implications for tumor immunogenicity
27. Induction of determinant spreading and of Th1 responses by in vitro stimulation with HER-2 peptides
28. A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer
29. Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials
30. A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer
31. Cellular resistance to the antimelanoma immunotoxin ZME-gelonin and strategies to target resistant cells
32. An antimelanoma immunotoxin containing recombinant human tumor necrosis factor: tissue disposition, pharmacokinetic, and therapeutic studies in xenograft models
33. Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the antimelanoma immunotoxin ZME-gelonin
34. Rab-GTPases: dual roles in vesicular transport and viral replication
35. Internalized Pseudomonas Exotoxin A can Exploit Multiple Pathways to Reach the Endoplasmic Reticulum
36. Clinical pharmacology and tissue disposition studies of131I-labeled anticolorectal carcinoma human monoclonal antibody LiCO 16.88
37. Phase I trial of chimeric (human-mouse) monoclonal antibody L6 in patients with non-small-cell lung, colon, and breast cancer
38. Radiolabeled antibody therapy in non-Hodgkins lymphoma: radiation protection, isotope comparisons and quality of life issues
39. Augmentation of interleukin-2-induced activation of human melanoma tumor-infiltrating lymphocytes by heteroconjugate antibody
40. Alteration in interactions between tumor-infiltrating lymphocytes and tumor cells in human melanomas after chemotherapy or immunotherapy
41. Phase I and II Study of Exisulind in Combination With Capecitabine in Patients With Metastatic Breast Cancer
42. Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter Syndrome
43. Safety of Yttrium-90 Ibritumomab Tiuxetan Radioimmunotherapy for Relapsed Low-Grade, Follicular, or Transformed Non-Hodgkin’s Lymphoma
44. Modification of methyliminodiacetato-trans-R, R-1,2-diamminocyclohexane platinum(II) pharmacology using a platinum-specific monoclonal antibody
45. Immunotherapy for Low-Grade Non-Hodgkin Secondary Lymphoma of the Orbit
46. Phase II Study of Weekly Docetaxel and Trastuzumab for Patients With HER-2–Overexpressing Metastatic Breast Cancer
47. Cationic Liposome-Mediated E1A Gene Transfer to Human Breast and Ovarian Cancer Cells and Its Biologic Effects: A Phase I Clinical Trial
48. Phase I Study of Stealth Liposomal Doxorubicin in Combination With Gemcitabine in the Treatment of Patients With Metastatic Breast Cancer
49. Lipid Bilayer Simulations of CXCR4 with Inverse Agonists and Weak Partial Agonists
50. Chapter 15 - MUC1 and Cancer Immunotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.